Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

SB-224289

From Wikipedia, the free encyclopedia

Pharmaceutical compound
SB-224289
Clinical data
Other namesSB224289
Drug classSerotonin5-HT1B receptorantagonist orinverse agonist
Identifiers
  • [4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]-(1'-methylspiro[6,7-dihydro-2H-furo[2,3-f]indole-3,4'-piperidine]-5-yl)methanone
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC32H32N4O3
Molar mass520.633 g·mol−1
3D model (JSmol)
  • CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)N4CCC5=CC6=C(C=C54)C7(CCN(CC7)C)CO6
  • InChI=1S/C32H32N4O3/c1-20-16-25(30-33-21(2)39-34-30)8-9-26(20)22-4-6-23(7-5-22)31(37)36-13-10-24-17-29-27(18-28(24)36)32(19-38-29)11-14-35(3)15-12-32/h4-9,16-18H,10-15,19H2,1-3H3
  • Key:ATQMRMGXINTJHV-UHFFFAOYSA-N

SB-224289 is aselectiveserotonin5-HT1B receptorantagonist orinverse agonist which is used inscientific research.[1][2][3][4][5] It is more than 75-fold selective for the serotonin 5-HT1B receptor over all otherserotonin receptors.[3] The drug indirectly increases serotonin release by blocking inhibitory serotonin 5-HT1Bautoreceptors.[1][3] In addition to its serotonin 5-HT1B receptor antagonism, SB-224289 has subsequently been found to counteract theantifungal effects of the marinedepsipeptidepapuamide A.[6]

References

[edit]
  1. ^abRoberts C, Price GW, Middlemiss DN (November 2001). "Ligands for the investigation of 5-HT autoreceptor function".Brain Research Bulletin.56 (5):463–469.doi:10.1016/s0361-9230(01)00628-1.PMID 11750791.
  2. ^Stenfors C, Ross SB (June 2002). "Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs".Naunyn-Schmiedeberg's Archives of Pharmacology.365 (6):462–467.doi:10.1007/s00210-002-0564-8.PMID 12070760.
  3. ^abcSelkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, et al. (September 1998)."SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity".British Journal of Pharmacology.125 (1):202–208.doi:10.1038/sj.bjp.0702059.PMC 1565605.PMID 9776361.
  4. ^Slassi A (June 2002). "Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications".Current Topics in Medicinal Chemistry.2 (6):559–574.doi:10.2174/1568026023393903.PMID 12052194.
  5. ^Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, et al. (April 1998). "The selective 5-HT1B receptor inverse agonist (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo".Journal of Medicinal Chemistry.41 (8):1218–1235.doi:10.1021/jm970457s.PMID 9548813.
  6. ^Cassilly CD, Maddox MM, Cherian PT, Bowling JJ, Hamann MT, Lee RE, et al. (2016)."SB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide A".PLOS ONE.11 (5) e0154932.Bibcode:2016PLoSO..1154932C.doi:10.1371/journal.pone.0154932.PMC 4868317.PMID 27183222.
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thispsychoactive drug-related article is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=SB-224289&oldid=1328693156"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp